Athos announces research collaboration to advance precision medicine in inflammatory bowel disease

Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples

India’s first homegrown mRNA COVID-19 vaccine likely to have low market penetration, says GlobalData

Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small

Mandaviya calls for collaboration to eliminate vector borne diseases

We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region

Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing

Evonik launches non-animal-derived collagen platform for medical device applications

Fermentation-based manufacturing leverages Evonik’s biotechnology platform

NHA announces successful onboarding of 1 lakh+ healthcare facilities

It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers

Wacker to expand mRNA-based actives capacity at Halle, Germany

Company is investing more than €100 million in the expansion of the Halle site

Clinical study of PD-L1 antibody ASC22 for cure of HIV completes first patient dosing

Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection

Microsize launched as Independent pharma services company

Meets the growing need for US-based API solubility and bioavailability enhancement services

Ascentage Pharma gets IND clearance by the US FDA for novel EED Inhibitor APG-5918

This multicenter, open-label Phase I study is designed to assess the safety and tolerability